Stock Events

Stock Events

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) Q4 2022 Earnings

NAMS+
31MarExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-1.8
-1.17
-0.55
0.08

Details

Expected EPS
-0.49
Actual EPS
-1.8
Surprise EPS
-1.31
Surprise Percent
+267.35%

Description

NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of -1.8 per share for Q4 2022.

0 Comments

Share your thoughts